Kai C. Wollert
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Kai C. Wollert

Carl Neuberg Str. 1, 
Hannover, NI, DE 
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Carl Neuberg Str. 1, 
Hannover, NI, DE 
OverviewLocationsClinical Research

Overview

Kai Wollert practices in Hannover, Germany. Wollert is rated as an Experienced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Their top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Bone Marrow Transplant, and Percutaneous Coronary Intervention (PCI).

Their clinical research consists of co-authoring 118 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Locations

Carl Neuberg Str. 1, Hannover, NI 30625, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction.
Enrollment Status: Completed
Publish Date: April 13, 2021
Intervention Type: Procedure
Study Phase: Phase 3

118 Total Publications

Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15 - impact on poor prognosis and impaired responsiveness to immunotherapy.
Mitotane treatment of adrenocortical carcinoma induces tumoural secretion of GDF-15 - impact on poor prognosis and impaired responsiveness to immunotherapy.
Journal: European journal of endocrinology
Published: November 25, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wollert's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile